Day: July 19, 2021

Not for Distribution to U.S. Newswire Services or for Dissemination in the United States MIRAMICHI, New Brunswick, July 19, 2021 (GLOBE NEWSWIRE) — SLAM Exploration Ltd. (TSXV: SXL) (the “Company”) announces that it has closed the previously announced private placement and it has issued 3,299,731 flow-through units (the “FT Units”) at a price of $0.09 per FT Unit for gross proceeds of $296,975.79 (the “Private Placement”). Each FT Unit is comprised of one common share in the capital of the Company issued on a “flow-through” basis and one-half of one common share purchase warrant issued on a non-flow-through basis (with two half common share purchase warrants being a “Warrant”). Each Warrant will entitle the holder thereof to acquire one non-flow-through common share at a price of $0.10 for a period of 24 months from the date of...

Alma íbúðafélag hf. hefur samþykkt tilboð um kaup á fasteignum að Elliðabraut 4-10, Reykjavík. Um er að ræða allt að 83 íbúðir sem afhendast á næstu 9 mánuðum. Kaupverðið er allt að 5.080 milljónir. Kaupin eru ýmsum fyrirvörum háð en stefnt er að því að aflétta þeim á næstu sex vikum. Kaupin eru í samræmi við stefnu félagsins um að stuðla að auknu framboði leiguhúsnæðis á höfuðborgarsvæðinu. Nánari upplýsingar veitir Ingólfur Árni Gunnarsson, framkvæmdastjóri – netfang ingolfur@al.is.

Miami, FL., July 19, 2021 (GLOBE NEWSWIRE) — Clover Leaf Capital Corp. (Nasdaq: CLOEU) (“Clover Leaf” or the “Company”) today announced the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units are expected to be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “CLOEU” beginning July 20, 2021. Each unit consists of one share of Class A common stock and one right to receive one-eighth (1/8) of one share of Class A common stock upon the consummation of the Company’s initial business combination.  Once the securities comprising the units begin separate trading, the shares of Class A common stock and rights are expected to be traded on the Nasdaq under the symbols “CLOE” and “CLOER,” respectively. Maxim Group LLC is acting as sole book-running manager for...

MIRAMAR, Fla., July 19, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (NASDAQ:HCWB) (the “Company”), an innovative preclinical stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced the pricing of an underwritten initial public offering of 7,000,000 shares of common stock at a public offering price of $8.00 per share for gross proceeds of approximately $56.0 million, prior to deducting underwriting discounts, commissions, and other offering expenses. All of the shares of common stock are being offered by the Company. The shares are expected to begin trading on the Nasdaq Global Market on July 20, 2021, under the ticker symbol “HCWB”. The offering is expected...

Overland Park, Kansas, July 19, 2021 (GLOBE NEWSWIRE) — TortoiseEcofin Acquisition Corp. III (the “Company”) today announced the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on the New York Stock Exchange (the “NYSE”) and trade under the ticker symbol “TRTL.U” beginning July 20, 2021. Each unit consists of one of the Company’s Class A ordinary shares and one-fourth of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one of the Company’s Class A ordinary shares at an exercise price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on the NYSE under the symbols “TRTL” and “TRTL WS,” respectively. Barclays, Goldman Sachs...

WILMINGTON, Del., July 19, 2021 (GLOBE NEWSWIRE) — Ashland Global Holdings Inc. (NYSE: ASH) will issue its third-quarter earnings release at approximately 5 p.m. ET on Tuesday, July 27, 2021. The company’s live webcast with securities analysts and investors will take place at 9 a.m. ET, Wednesday, July 28, 2021 and include an executive summary and detailed remarks. Simultaneously, the company will post a slide presentation in the Investor Relations section of its website http://investor.ashland.com.    Among those participating in the webcast presentation will be:Guillermo Novo, chairman and chief executive officer; Kevin Willis, senior vice president and chief financial officer; and Seth Mrozek, director of investor relations.The webcast and supporting materials will be accessible through the Investor Relations section of...

First Solar Appoints Anita Marangoly George to Board of DirectorsFirst Solar has appointed Anita Marangoly George, a senior executive with almost four decades of diverse global experience in institutional finance and sustainable infrastructure investing, to its board of directors, effective July 19, 2021.TEMPE, Ariz., July 19, 2021 (GLOBE NEWSWIRE) — First Solar, Inc. (Nasdaq: FSLR) has appointed Anita Marangoly George, a senior executive with almost four decades of diverse global experience in institutional finance and sustainable infrastructure investing, to its board of directors, effective July 15, 2021. Ms. George will serve on First Solar’s Nominating and Governance, and Technology Committees. Ms. George has held various positions at la Caisse de Dépôt et Placement du Québec (CDPQ), a global investment group...

BOULDER, Colo., July 19, 2021 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (Nasdaq: BBI) (“Brickell” or the “Company”), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that it has entered into an underwriting agreement with H.C. Wainwright & Co., LLC under which the underwriter has agreed to purchase on a firm commitment basis 8,064,517 shares of common stock of the Company at a price to the public of $0.62 per share, less underwriting discounts and commissions. The closing of the public offering is expected to occur on or about July 22, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company...

MENLO PARK, Calif., July 19, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc., a growth-stage medical device company focused on the development and commercialization of proprietary devices that target the underlying causes of the world’s most prevalent eye diseases, today announced the closing of its initial public offering of 11,500,000 shares of common stock including the exercise in full of the underwriters’ option to purchase 1,500,000 additional shares of common stock, at the initial public offering price of $24.00 per share. The total gross proceeds to Sight Sciences, before deducting underwriting discounts and commissions and offering expenses, were approximately $276 million. Shares of Sight Sciences’s common stock began trading on the Nasdaq Global Market on July 15, 2021, under the ticker symbol “SGHT.” Morgan Stanley and...